Literature DB >> 35333929

Effects of human Muse cells on bladder inflammation, overactivity, and nociception in a chemically induced Hunner-type interstitial cystitis-like rat model.

Akira Furuta1, Yasumasa Kuroda2, Tokunori Yamamoto3, Shin Egawa4, Mari Dezawa2, Naoki Yoshimura5.   

Abstract

INTRODUCTION AND HYPOTHESIS: We investigated the effects of locally administered human multilineage-differentiating stress enduring (Muse) cells, nontumorigenic pluripotent-like endogenous stem cells, on bladder tissues, function, and nociceptive behavior in a chemically induced Hunner-type interstitial cystitis (HIC)-like rat model without immunosuppressant.
METHODS: Chemical cystitis was induced by intravesical instillation of 0.2 N hydrochloride (HCl) for 15 min in female F344 rats. SSEA-3+ Muse cells, SSEA-3- non-Muse cells or Hanks' balanced salt solution (HBSS; vehicle) were injected into the anterior and posterior bladder wall at each 1×104 cells/10 μl 6 h after HCl application. The sham group received HBSS without HCl instillation. Urinary frequency was assessed using metabolic cages, cystometrograms, nociceptive behavior, and histological analysis of the bladder and L6 spinal cord.
RESULTS: Increases in urinary frequency and decreases in bladder capacity compared with the sham group were observed in the vehicle and non-Muse groups, but not in the Muse group, at 1 week. Significant increases in nociceptive behavior compared with the sham group and the expression of TNFα in the bladder and c-Fos in the bilateral dorsal horns of L6 spinal cord were also observed in the vehicle and non-Muse groups, whereas these changes were not seen in the Muse group at 1 week. Histological analysis exhibited a higher proportion of injected Muse cells remaining in the urothelial basal layer and lamina propria of the bladder than non-Muse cells until 4 weeks.
CONCLUSIONS: Muse cell therapy could be a promising modality for treating HIC.
© 2022. The International Urogynecological Association.

Entities:  

Keywords:  Animal model; Hunner lesions; Interstitial cystitis; Muse cells; Treatment

Mesh:

Substances:

Year:  2022        PMID: 35333929     DOI: 10.1007/s00192-022-05166-w

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   1.932


  26 in total

Review 1.  Muse Cells Provide the Pluripotency of Mesenchymal Stem Cells: Direct Contribution of Muse Cells to Tissue Regeneration.

Authors:  Mari Dezawa
Journal:  Cell Transplant       Date:  2016-02-15       Impact factor: 4.064

2.  Mesenchymal Stem Cell Therapy Alleviates Interstitial Cystitis by Activating Wnt Signaling Pathway.

Authors:  Miho Song; Jisun Lim; Hwan Yeul Yu; Junsoo Park; Ji-Youn Chun; Jaeho Jeong; Jinbeom Heo; Hyunsook Kang; YongHwan Kim; Yong Mee Cho; Seong Who Kim; Wonil Oh; Soo Jin Choi; Sung-Wuk Jang; Sanghyeok Park; Dong-Myung Shin; Myung-Soo Choo
Journal:  Stem Cells Dev       Date:  2015-04-09       Impact factor: 3.272

3.  Angiogenesis in bladder tissues is strongly correlated with urinary frequency and bladder pain in patients with interstitial cystitis/bladder pain syndrome.

Authors:  Akira Furuta; Yasuyuki Suzuki; Taro Igarashi; Yusuke Koike; Takahiro Kimura; Shin Egawa; Naoki Yoshimura
Journal:  Int J Urol       Date:  2019-06       Impact factor: 3.369

4.  Unique multipotent cells in adult human mesenchymal cell populations.

Authors:  Yasumasa Kuroda; Masaaki Kitada; Shohei Wakao; Kouki Nishikawa; Yukihiro Tanimura; Hideki Makinoshima; Makoto Goda; Hideo Akashi; Ayumu Inutsuka; Akira Niwa; Taeko Shigemoto; Yoko Nabeshima; Tatsutoshi Nakahata; Yo-Ichi Nabeshima; Yoshinori Fujiyoshi; Mari Dezawa
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

5.  Bladder wall injection of mesenchymal stem cells ameliorates bladder inflammation, overactivity, and nociception in a chemically induced interstitial cystitis-like rat model.

Authors:  Akira Furuta; Tokunori Yamamoto; Taro Igarashi; Yasuyuki Suzuki; Shin Egawa; Naoki Yoshimura
Journal:  Int Urogynecol J       Date:  2018-03-06       Impact factor: 2.894

6.  TGF-β/MAPK signaling mediates the effects of bone marrow mesenchymal stem cells on urinary control and interstitial cystitis after urinary bladder transplantation.

Authors:  Ya Xiao; Ya-Jun Song; Bo Song; Chi-Bing Huang; Qing Ling; Xiao Yu
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

7.  Clinical guidelines for interstitial cystitis/bladder pain syndrome.

Authors:  Yukio Homma; Yoshiyuki Akiyama; Hikaru Tomoe; Akira Furuta; Tomohiro Ueda; Daichi Maeda; Alex Tl Lin; Hann-Chorng Kuo; Ming-Huei Lee; Seung-June Oh; Joon Chul Kim; Kyu-Sung Lee
Journal:  Int J Urol       Date:  2020-04-14       Impact factor: 3.369

8.  S1P-S1PR2 Axis Mediates Homing of Muse Cells Into Damaged Heart for Long-Lasting Tissue Repair and Functional Recovery After Acute Myocardial Infarction.

Authors:  Yoshihisa Yamada; Shohei Wakao; Yoshihiro Kushida; Shingo Minatoguchi; Atsushi Mikami; Kenshi Higashi; Shinya Baba; Taeko Shigemoto; Yasumasa Kuroda; Hiromitsu Kanamori; Mohamad Amin; Masanori Kawasaki; Kazuhiko Nishigaki; Masato Taoka; Toshiaki Isobe; Chisako Muramatsu; Mari Dezawa; Shinya Minatoguchi
Journal:  Circ Res       Date:  2018-02-23       Impact factor: 17.367

9.  Mesenchymal stem cells protect against the tissue fibrosis of ketamine-induced cystitis in rat bladder.

Authors:  Aram Kim; Hwan Yeul Yu; Jinbeom Heo; Miho Song; Jung-Hyun Shin; Jisun Lim; Soo-Jung Yoon; YongHwan Kim; Seungun Lee; Seong Who Kim; Wonil Oh; Soo Jin Choi; Dong-Myung Shin; Myung-Soo Choo
Journal:  Sci Rep       Date:  2016-08-02       Impact factor: 4.379

10.  Hunner-Type (Classic) Interstitial Cystitis: A Distinct Inflammatory Disorder Characterized by Pancystitis, with Frequent Expansion of Clonal B-Cells and Epithelial Denudation.

Authors:  Daichi Maeda; Yoshiyuki Akiyama; Teppei Morikawa; Akiko Kunita; Yasunori Ota; Hiroto Katoh; Aya Niimi; Akira Nomiya; Shumpei Ishikawa; Akiteru Goto; Yasuhiko Igawa; Masashi Fukayama; Yukio Homma
Journal:  PLoS One       Date:  2015-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.